Opexa Therapeutics, Inc. (OPXA) Reports Q1 Loss of $0.13

May 14, 2014 4:12 PM EDT

Opexa Therapeutics, Inc. (NASDAQ: OPXA) reported Q1 EPS of ($0.13), versus ($0.58) reported last year. Revenue for the quarter came in at $348.8 thousand, versus $220.1 thousand reported last year.

For earnings history and earnings-related data on Opexa Therapeutics, Inc. (OPXA) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings